Non-Invasive Prenatal Screening (NIPS) Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: NCF322AAE6B4EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Non-Invasive Prenatal Screening (NIPS) in Global, including the following market information:

Global Non-Invasive Prenatal Screening (NIPS) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Non-Invasive Prenatal Screening (NIPS) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trisomy 21 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-Invasive Prenatal Screening (NIPS) include Myriad Genetics, Illumina, Progenity, Natera, Yourgene Health, Roche Sequencing Solutions (RSS), Eurofins LifeCodexx GmbH, Labcorp and PerkinElmer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Prenatal Screening (NIPS) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-Invasive Prenatal Screening (NIPS) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Non-Invasive Prenatal Screening (NIPS) Market Segment Percentages, by Type, 2021 (%)

• Trisomy 21
• Trisomy 18
• Trisomy 13
• Sex Chromosome Aneuploidies
• Others

Global Non-Invasive Prenatal Screening (NIPS) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Non-Invasive Prenatal Screening (NIPS) Market Segment Percentages, by Application, 2021 (%)

• Clinical Laboratories
• Hospital

Global Non-Invasive Prenatal Screening (NIPS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Non-Invasive Prenatal Screening (NIPS) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-Invasive Prenatal Screening (NIPS) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Non-Invasive Prenatal Screening (NIPS) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Myriad Genetics
• Illumina
• Progenity
• Natera
• Yourgene Health
• Roche Sequencing Solutions (RSS)
• Eurofins LifeCodexx GmbH
• Labcorp
• PerkinElmer
• Harmony

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Non-Invasive Prenatal Screening (NIPS) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Non-Invasive Prenatal Screening (NIPS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NON-INVASIVE PRENATAL SCREENING (NIPS) OVERALL MARKET SIZE

2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size: 2021 VS 2028
2.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Non-Invasive Prenatal Screening (NIPS) Players in Global Market
3.2 Top Global Non-Invasive Prenatal Screening (NIPS) Companies Ranked by Revenue
3.3 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Companies
3.4 Top 3 and Top 5 Non-Invasive Prenatal Screening (NIPS) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-Invasive Prenatal Screening (NIPS) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Invasive Prenatal Screening (NIPS) Players in Global Market
  3.6.1 List of Global Tier 1 Non-Invasive Prenatal Screening (NIPS) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Non-Invasive Prenatal Screening (NIPS) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Non-Invasive Prenatal Screening (NIPS) Market Size Markets, 2021 & 2028
  4.1.2 Trisomy
  4.1.3 Trisomy
  4.1.4 Trisomy
  4.1.5 Sex Chromosome Aneuploidies
  4.1.6 Others
4.2 By Type - Global Non-Invasive Prenatal Screening (NIPS) Revenue & Forecasts
  4.2.1 By Type - Global Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2022
  4.2.2 By Type - Global Non-Invasive Prenatal Screening (NIPS) Revenue, 2023-2028
  4.2.3 By Type - Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Non-Invasive Prenatal Screening (NIPS) Market Size, 2021 & 2028
  5.1.2 Clinical Laboratories
  5.1.3 Hospital
5.2 By Application - Global Non-Invasive Prenatal Screening (NIPS) Revenue & Forecasts
  5.2.1 By Application - Global Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2022
  5.2.2 By Application - Global Non-Invasive Prenatal Screening (NIPS) Revenue, 2023-2028
  5.2.3 By Application - Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Non-Invasive Prenatal Screening (NIPS) Market Size, 2021 & 2028
6.2 By Region - Global Non-Invasive Prenatal Screening (NIPS) Revenue & Forecasts
  6.2.1 By Region - Global Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2022
  6.2.2 By Region - Global Non-Invasive Prenatal Screening (NIPS) Revenue, 2023-2028
  6.2.3 By Region - Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2028
  6.3.2 US Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.3.3 Canada Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.3.4 Mexico Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2028
  6.4.2 Germany Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.4.3 France Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.4.4 U.K. Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.4.5 Italy Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.4.6 Russia Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.4.7 Nordic Countries Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.4.8 Benelux Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2028
  6.5.2 China Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.5.3 Japan Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.5.4 South Korea Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.5.5 Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.5.6 India Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2028
  6.6.2 Brazil Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.6.3 Argentina Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2028
  6.7.2 Turkey Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.7.3 Israel Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.7.4 Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028
  6.7.5 UAE Non-Invasive Prenatal Screening (NIPS) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Myriad Genetics
  7.1.1 Myriad Genetics Corporate Summary
  7.1.2 Myriad Genetics Business Overview
  7.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.1.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.1.5 Myriad Genetics Key News
7.2 Illumina
  7.2.1 Illumina Corporate Summary
  7.2.2 Illumina Business Overview
  7.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.2.4 Illumina Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.2.5 Illumina Key News
7.3 Progenity
  7.3.1 Progenity Corporate Summary
  7.3.2 Progenity Business Overview
  7.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.3.4 Progenity Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.3.5 Progenity Key News
7.4 Natera
  7.4.1 Natera Corporate Summary
  7.4.2 Natera Business Overview
  7.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.4.4 Natera Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.4.5 Natera Key News
7.5 Yourgene Health
  7.5.1 Yourgene Health Corporate Summary
  7.5.2 Yourgene Health Business Overview
  7.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.5.4 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.5.5 Yourgene Health Key News
7.6 Roche Sequencing Solutions (RSS)
  7.6.1 Roche Sequencing Solutions (RSS) Corporate Summary
  7.6.2 Roche Sequencing Solutions (RSS) Business Overview
  7.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.6.4 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.6.5 Roche Sequencing Solutions (RSS) Key News
7.7 Eurofins LifeCodexx GmbH
  7.7.1 Eurofins LifeCodexx GmbH Corporate Summary
  7.7.2 Eurofins LifeCodexx GmbH Business Overview
  7.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.7.4 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.7.5 Eurofins LifeCodexx GmbH Key News
7.8 Labcorp
  7.8.1 Labcorp Corporate Summary
  7.8.2 Labcorp Business Overview
  7.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.8.4 Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.8.5 Labcorp Key News
7.9 PerkinElmer
  7.9.1 PerkinElmer Corporate Summary
  7.9.2 PerkinElmer Business Overview
  7.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.9.4 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.9.5 PerkinElmer Key News
7.10 Harmony
  7.10.1 Harmony Corporate Summary
  7.10.2 Harmony Business Overview
  7.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Major Product Offerings
  7.10.4 Harmony Non-Invasive Prenatal Screening (NIPS) Revenue in Global Market (2017-2022)
  7.10.5 Harmony Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Non-Invasive Prenatal Screening (NIPS) Market Opportunities & Trends in Global Market
Table 2. Non-Invasive Prenatal Screening (NIPS) Market Drivers in Global Market
Table 3. Non-Invasive Prenatal Screening (NIPS) Market Restraints in Global Market
Table 4. Key Players of Non-Invasive Prenatal Screening (NIPS) in Global Market
Table 5. Top Non-Invasive Prenatal Screening (NIPS) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-Invasive Prenatal Screening (NIPS) Product Type
Table 9. List of Global Tier 1 Non-Invasive Prenatal Screening (NIPS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Invasive Prenatal Screening (NIPS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-Invasive Prenatal Screening (NIPS) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-Invasive Prenatal Screening (NIPS) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-Invasive Prenatal Screening (NIPS) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-Invasive Prenatal Screening (NIPS) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2023-2028
Table 30. Myriad Genetics Corporate Summary
Table 31. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 32. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 33. Illumina Corporate Summary
Table 34. Illumina Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 35. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 36. Progenity Corporate Summary
Table 37. Progenity Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 38. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 39. Natera Corporate Summary
Table 40. Natera Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 41. Natera Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 42. Yourgene Health Corporate Summary
Table 43. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 44. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 45. Roche Sequencing Solutions (RSS) Corporate Summary
Table 46. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 47. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 48. Eurofins LifeCodexx GmbH Corporate Summary
Table 49. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 50. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 51. Labcorp Corporate Summary
Table 52. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 53. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 54. PerkinElmer Corporate Summary
Table 55. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 56. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)
Table 57. Harmony Corporate Summary
Table 58. Harmony Non-Invasive Prenatal Screening (NIPS) Product Offerings
Table 59. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Non-Invasive Prenatal Screening (NIPS) Segment by Type in 2021
Figure 2. Non-Invasive Prenatal Screening (NIPS) Segment by Application in 2021
Figure 3. Global Non-Invasive Prenatal Screening (NIPS) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-Invasive Prenatal Screening (NIPS) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue in 2021
Figure 8. By Type - Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 12. US Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 16. Germany Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 24. China Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 30. Brazil Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Revenue Market Share, 2017-2028
Figure 33. Turkey Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-Invasive Prenatal Screening (NIPS) Revenue, (US$, Mn), 2017-2028
Figure 37. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Natera Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)